Elbit Systems Announces the Filing of its Annual Report on Form 20-F for Fiscal Year 2024
HAIFA, Israel, March 20, 2025 /PRNewswire/ — Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) (“Elbit Systems” or the “Company”) announced... Read more.
Zeekr Group Announced Unaudited Pro Forma Condensed Combined Financial Information
HANGZHOU, China, March 20, 2025 /PRNewswire/ — ZEEKR Intelligent Technology Holding Limited (“Zeekr Group” or the “Company”) (NYSE:... Read more.
VIAVI Highlights Test Solutions for AI Infrastructure Development, Manufacturing and Deployment at OFC 2025
At booth 2319, VIAVI will showcase three new products supporting the transition to next-gen AI infrastructure CHANDLER, Ariz., March 20, 2025 /PRNewswire/ — VIAVI... Read more.
Quarterhill to Exhibit at the 2025 IBTTA Technology Summit in Dallas, Texas
Quarterhill Inc. is a platinum sponsor and exhibitor at the IBTTA Technology Summit, a key platform for discussing the future of tolling technology, which will take... Read more.
HUYA Inc. Announces Ex-dividend Date for Recently Announced Cash Dividend
GUANGZHOU, China, March 20, 2025 /PRNewswire/ — HUYA Inc. (“Huya” or the “Company”) (NYSE: HUYA), a leading game live streaming platform... Read more.
Paradigm Health Announces Oncology and Healthcare Expert Dr. Karen E. Knudsen Appointed to Board of Directors and Launch of New AI-Driven Solution for Clinical Trial Data Collection and Management
COLUMBUS, Ohio, March 20, 2025 /PRNewswire/ — Paradigm Health, which is rebuilding the clinical research ecosystem, today announced the appointment of Karen... Read more.
Caris Life Sciences Publishes Study Featuring the Largest Real-World Cohort of Tissue-Agnostic Indications Revealing Over 20 Percent of Patients Are Eligible for “Pan-Cancer” Therapies
A 295,000+ patient study revealed variable efficacy among cancers for patients treated with tissue-agnostic drugs and uncovered the potential for expanding approvals... Read more.
iOnctura commences randomized Phase II study in metastatic uveal melanoma
First patient dosed in Phase II OCULE-01 study with roginolisib, an allosteric modulator of PI3Kδ The European Medicines Agency (EMA) has granted Orphan Drug Designation... Read more.
Rock Tech Lithium Partners with GEA for Key Equipment in Guben Lithium Converter
Rock Tech Lithium partners with GEA Group AG, a global leader in process technology, to supply crystallization and zero-liquid discharge systems for its Lithium... Read more.
Yiren Digital Reports Fourth Quarter and Fiscal Year 2024 Financial Results
BEIJING, March 20, 2025 /PRNewswire/ — Yiren Digital Ltd. (NYSE: YRD) (“Yiren Digital” or the “Company”), an AI-powered platform providing... Read more.